definiens: ), Such exclusivity may be defined by the applicab le Drug, the Drug class, the intended use, or a therapeutic area . If such exclusivity is requested by scPharma, scPharma ’s notice will contain certain milestones required to maintain such exclusivity . Such milesto nes may relate to [ * * * ] . Sensile shall respond to s uch exclusivity request within [ * * * ] with acceptance or denial of the request for exclusivity . In the even t Sensile accepts such request by written notice to scPharma ( the ), scPharma shall pay Sensile a royalty on Net Sales of such Product as s et forth in Section 3 below . For each Additional Fi eld granted to scPharma exclusively, the Incremental Disposable Units volume established in Exhibit 2.6(a ) will be added to the Minimum Volumes . The following example is to cl arify the aggregate minimum volumes : [ * * * ]